Modulating Inflammatory and Fibrogenic Pathways in Kidney Disease using a novel antagonist of Protease-Activated-Receptor-2 [ 2015 - 2017 ]

Research Grant

Researchers: Dr David Vesey (Principal investigator) ,  A/Pr David Nikolic-Paterson ,  A/Pr Glenda Gobe ,  Dr Jacky Suen ,  Dr Rink-Jan Lohman

Brief description Chronic kidney disease (CKD) now affects 10% of adults in industrialised countries. Current treatments are largely ineffective. Thus developing better CKD treatments will have substantial public health benefit. Three well established and clinically relevant animal models of kidney disease will be used to test the ability of a new experimental anti-inflammatory drug, developed by members of this research team at The University of Queensland, to prevent or lessen the progression of CKD.

Funding Amount $AUD 598,282.84

Funding Scheme Project Grants

Notes Standard Project Grant